Net profit of Syncom Formulations (India) rose 45.46% to Rs 18.91 crore in the quarter ended December 2025 as against Rs 13.00 crore during the previous quarter ended December 2024. Sales declined 9.72% to Rs 115.14 crore in the quarter ended December 2025 as against Rs 127.53 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales115.14127.53 -10 OPM %18.4211.55 - PBDT26.4518.57 42 PBT25.0917.26 45 NP18.9113.00 45 Powered by Capital Market - Live News

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live News

Net profit of Syncom Formulations (India) rose 49.41% to Rs 16.60 crore in the quarter ended September 2025 as against Rs 11.11 crore during the previous quarter ended September 2024. Sales rose 18.97% to Rs 121.72 crore in the quarter ended September 2025 as against Rs 102.31 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales121.72102.31 19 OPM %15.1211.89 - PBDT23.3916.15 45 PBT22.0414.85 48 NP16.6011.11 49 Powered by Capital Market - Live News

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Syncom Formulations (India) announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live News